The 2024 ISPE Biotechnology Conference will occur on 17-18 June
in Boston, Massachusetts, USA, and
virtually.
NORTH
BETHESDA, Md., May 8, 2024
/PRNewswire-PRWeb/ -- The International Society for Pharmaceutical
Engineering (ISPE) has announced featured speakers and a focus on
digital innovation for the 2024 ISPE Biotechnology Conference.
The focus on integrating new technologies and pioneering
strategies aligns with ISPE's commitment to staying at the
forefront of industry trends. The conference provides a unique
platform for engaging with a wide array of professionals hailing
from the pharmaceutical and biopharmaceutical sectors, encompassing
manufacturers, technological specialists, academic researchers, and
global regulatory authorities.
"The conference is poised to be a transformative event,
providing an in-depth examination of pivotal domains and
advancements in biotechnology that are defining the future
trajectory of our industry," said Phillip
Smith, 2024 ISPE Biotechnology Conference Chair and Director
of Process Technology, GSK.
This year's conference will delve into essential topics situated
at the nexus of innovation and regulation, including:
•Artificial Intelligence (AI): Gain insights into how AI is
revolutionizing biotech manufacturing processes, particularly in
emerging fields such as ATMPs and gene therapy
•Data Science-Assisted Tech Transfer: Discover the role of data
science in streamlining biopharmaceutical technology transfer while
ensuring compliance with regulatory standards
•Sustainability: Explore strategies for enhancing environmental
sustainability within the biopharmaceutical industry, in alignment
with global benchmarks
•Quality and Regulatory: Gain an understanding of the significance
of digitalized quality management in upholding regulatory
compliance and ensuring the reliability of the supply chain
•Novel Technology Innovations: Explore cutting-edge advancements in
biopharmaceutical manufacturing that meet stringent regulatory
criteria
•Lifecycle Strategies: Discuss strategies for expediting
commercialization and refining product life cycle management
•Facility Design: Examine trends and regulatory mandates in
biopharmaceutical facility design to ensure adherence to industry
standards
Featured speakers include:
•Piper Trelstad, PhD, Bill & Melinda Gates Research
Institute
•Robert Langer, PhD, Massachusetts Institute
of Technology (MIT)
•Rene-Pascal Fischer, Fraunhofer IESE
•Francesco Cicirello, BioNTech US Inc.; Richard Denk, SKAN AG
•Sharmista Chatterjee, PhD, FDA, OPMA
Learn more and register for the 2024 ISPE Biotechnology
Conference today by visiting ISPE.org/Bio24.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is
a global nonprofit association serving its members through leading
scientific, technical, and regulatory advancement across the entire
pharmaceutical lifecycle. The 22,000+ members of ISPE provide
solutions to complex pharmaceutical industry challenges through
innovation, member and workforce development, and technical,
regulatory, and compliance collaborations in more than 120
countries worldwide. Founded in 1980, ISPE has its worldwide
headquarters and training center in North
Bethesda, Maryland, USA, and its operations center in
Tampa, Florida, USA. For more
information, visit ISPE.org.
Media Contact
Katie LeChase, ISPE,
+1-360-718-9771, KLeChase@ISPE.org, https://ispe.org/
View original
content:https://www.prweb.com/releases/ispe-announces-featured-speakers-and-a-focus-on-digital-innovation-for-the-2024-ispe-biotechnology-conference-302140080.html
SOURCE ISPE